title: Fingolimod blocks immunosurveillance of myeloma and B-cell lymphoma resulting in cancer development in mice.
authors.forename: Kristina Berg
authors.initials: KB
authors.lastname: Lorvik
authors.forename: Bjarne
authors.initials: B
authors.lastname: Bogen
authors.forename: Alexandre
authors.initials: A
authors.lastname: Corthay
mesh_terms: D000818:Animals; D004195:Disease Models, Animal; D000068876:Fingolimod Hydrochloride; D007157:Immunologic Surveillance / Q000187:drug effects*; D007166:Immunosuppressive Agents / Q000494:pharmacology*; D016393:Lymphoma, B-Cell / Q000276:immunology*; D051379:Mice; D016513:Mice, SCID; D008822:Mice, Transgenic; D009101:Multiple Myeloma / Q000276:immunology*; D011409:Propylene Glycols / Q000494:pharmacology*; D013110:Sphingosine / Q000031:analogs & derivatives* / Q000494:pharmacology
chemical_list: D007166:Immunosuppressive Agents; D011409:Propylene Glycols; D000068876:Fingolimod Hydrochloride; D013110:Sphingosine